AGP Executive Report
Last update: 6 hours agoPharma Supply Chain Security: Pakistan’s health ministry says it will roll out a nationwide medicine barcode and QR-code verification system within 60 days, aiming to help people confirm products are genuine and registered as counterfeit and substandard drugs remain a major risk. Oncology & Breast Surgery Tech: New cost and workflow analyses compare breast localization approaches (wire-guided needle vs MOLLI) and sentinel node dye options (methylene blue vs indocyanine green), focusing on delays, complications, and cost-effectiveness. Prostate Cancer Testing: A clinician review of IsoPSA performance reports how results may shift biopsy decisions, including in patients who did not have pre-biopsy mpMRI and those with low-to-intermediate mpMRI findings. Eye Care Innovation: A small UK case series finds an artificial corneal endothelial implant reduced corneal thickness and improved vision in chronic corneal oedema, including some patients after failed grafts. Multiple Sclerosis Progression Clue: Research links “foamy” fat-loaded immune cells in brain tissue to faster MS progression, suggesting a potential way to identify higher-risk patients. Healthcare Business Watch: India’s Manipal Hospitals is reportedly preparing a major IPO targeting about a $10B valuation. Public Health Alerts: The CDC reports tick-linked alpha-gal allergy markers in up to 31% of blood samples in some states, and the FDA upgraded a Utz potato chip recall to its highest risk category over possible salmonella contamination.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.